Clinical Trials

Title   Eli Lilly I4T-MC-JVDD
Principal Investigator/ Physician   Moh’d Khushman, MD
Protocol No.   I4T-MC-JVDD
Open Date   03/25/2016
Cancer Site   Gastric (Stomach)
Status   Open
Sponsor   Eli Lilly
Contact Email   MCI Clinical Trials
Summary  

Protocol Title:  "Safety and Effectiveness of Ramucirumab in Patients with Advanced Gastric Cancer in European Union and North America:  A prospective Observational Registry."

Inclusion Criteria:  Advanced gastric cancer or GEJ adenocarcinoma that has progressed after prior chemotherapy and have initiated Ramucirumab treatment.

Exclusion Criteria:  Received more than 1 line of chemotherapy for advanced gastric or GEJ, or currently participating in any other study.

 

Email Newsletters

Connect With Us